OS Therapies submits patent application with US FDA covering biomarkers of immune response to Listeria monocytogenes: New York Saturday, April 18, 2026, 16:00 Hrs [IST] OS Therapi ...
Markets are moving together again, but the drivers behind this shift point to deeper structural changes. Learn how forces ...
Using Health and Retirement Study data, 31.9% show cognitive gains, and 28% improve gait speed over follow-up — findings that ...
New patent application covers treatment-emergent immune signature related to 'turning cold tumors hot' and the activation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results